Durable Response to Glofitamab in HIV‐Positive Refractory Burkitt Lymphoma: Case Report and Discussion

Glofitamab may represent a promising stand-alone option in relapsed BL, when conventional cytotoxic therapies are exhausted. <b>Clinical Trial Registration</b>: The authors have confirmed that clinical trial registration is not needed for this submission.

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2026-02-01
DOI
https://doi.org/10.1002/jha2.70243
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Durable Response to Glofitamab in HIV‐Positive Refractory Burkitt Lymphoma: Case Report and Discussion

Kiem Dominik, Beer Arno, Egle Alexander, Bozzotto Elisa et al.
eJHaem
Viral-associated cancers and disorders
article

Durable Response to Glofitamab in HIV‐Positive Refractory Burkitt Lymphoma: Case Report and Discussion

Kiem Dominik, Beer Arno, Egle Alexander, Bozzotto Elisa, Melchardt Thomas, Neureiter Daniel, Zellinger Barbara, Magnes Theresa
article en

Abstract

Glofitamab may represent a promising stand-alone option in relapsed BL, when conventional cytotoxic therapies are exhausted. <b>Clinical Trial Registration</b>: The authors have confirmed that clinical trial registration is not needed for this submission.

eJHaemVol. 7(1)
Paracelsus Medical University (AT)
Openalex Percentile: Top 58%
Viral-associated cancers and disorders
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Durable Response to Glofitamab in HIV‐Positive Refractory Burkitt Lymphoma: Case Report and Discussion — Kiem Dominik, Beer Arno, et al. · eJHaem (2026) | TGRS Research Map | TGRS